期刊文献+

CT引导下氩氦刀冷冻介入治疗肝癌不良反应实施治疗性干预的疗效观察 被引量:6

The curative effect of the therapeutic intervention that against the adverse reaction which caused by CT guided Argon-helium cryoablation therapy to hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨对CT引导下经皮肝穿刺氩氦刀冷冻介入术治疗肝癌过程中的不良反应实施干预的疗效。方法:回顾性分析68例经皮肝穿刺氩氦刀冷冻介入治疗肝癌的患者,在术后发生不良反应时给予相应的干预措施,采用心理干预措施、物理降温与药物降温相结合、止痛药物与心理干预相结合、止血药物与观察病情、有效的冻伤皮肤治疗、药物止吐、保障组织灌流及胃肠减压等方法,观察实施治疗性干预的疗效。结果:CT引导下经皮肝穿刺氩氦刀靶向冷冻介入术治疗肝癌中出现的不良反应,通过治疗性干预手段,其症状均得到改善,总有效率为93.7%。结论:全面细致地实施治疗性干预措施是氩氦刀介入治疗肝癌过程中重要的手段,疗效满意,可以有效地减少不良反应的发生,提高患者的生命质量。 Objective:To investigate the effect of the therapeutic intervention that against the adversereaction which caused by CT guided Argon-helium cryoablation to hepatocellular carcinoma.Methods:The retrospective analysis on the adverse reactions of 68 cases whom treated by Argon-helium cryoablation to hepatocellular carcinoma was conducted.The doctors gave appropriate interventions when the patients suffered adverse reactions after surgery,such as mental interventions,physical cooling combined with drug cooling,analgesic drugs combined with mental intervention;hemostatic drugs and observation,effective therapy on frostbite skin,antiemetic drugs using,protection of tissue perfusion,gastrointestinal decompression etc.Results:The adverse reaction which caused be CT guided Argon-helium cryoablation to hepatocellular carcinoma have been improved through giving therapeutic intervention.The total efficiency is 93.7%.Conclusion:Therapeuticintervention is one of critical steps during the argon-helium cryoablation therapy to hepatocellular carcinoma procedure.It can reduce the adverse reaction effectively and improve the quality of patients' life.
机构地区 解放军第
出处 《中国医学装备》 2013年第7期39-41,共3页 China Medical Equipment
关键词 氩氦刀 肝癌 CT 不良反应 治疗性干预 Argon-helium Hepatoma CT Adverse reaction Therapeutic intervention
  • 相关文献

参考文献7

二级参考文献41

共引文献401

同被引文献51

  • 1胡效坤,王明友,杨志国,邱春东,吕东方,李晓东,左太阳.CT导引下经皮穿刺组织间植入^(125)I放射微粒子治疗中心型肺癌的应用研究[J].中华放射学杂志,2004,38(9):910-915. 被引量:117
  • 2吴宇旋,窦永充,张彦舫,沈新颖,郑雪芬,孙国平,徐坚民.经皮射频消融治疗膈下肝癌[J].介入放射学杂志,2006,15(12):728-731. 被引量:16
  • 3胡效坤, 张福君.CT介入治疗学.2版.北京:人民卫生出版社, 2012:1056-1059.
  • 4Paul SB, Gamanagatti SR, Aneesh MK, et al. Percutaneous ablative therapy for hepatocellular carcinoma. Natl Med J India, 2011, 24(6):347-355.
  • 5Lencioni R, Modified LJ. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis, 2010, 30(1):52-60.
  • 6Llovet JM, Di Bisceglie AM, Bruix JA, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 2008,100(10):698-711.
  • 7Vogl TJ, Trapp M, Schroeder T, et al. Transarterial chemoembolization for hepatocellutar carcinoma:Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results form aliver transplanation center. Radiology, 2000,214(4):349-457.
  • 8Matsui O. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology, 1994,33(1):84-88.
  • 9胡效坤,尹成彬,王少奎,王永奎,金晶.CT引导下^(125)I放射粒子植入治疗胰腺恶性肿瘤[J].肿瘤研究与临床,2007,19(10):681-683. 被引量:14
  • 10杨宝亮,安云凤,徐富刚,张艳桥.氩氦刀治疗恶性肿瘤细胞免疫功能变化的临床分析[J].实用肿瘤学杂志,2009,23(2):143-145. 被引量:8

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部